G/TBT/N/PHL/292  
11 August 2022  
(22-6079) Page: 1/2 
Committee on Technical Barriers to Trade  Original:  English  
 
  
NOTIFICATION  
The following notification is being circulated in accordance with Article 10.6  
 
1. Notifying Member:  PHILIPPINES  
If applicable, name of local government involved (Article 3.2 and 7.2):   
2. Agency responsible:   
DR. OSCAR G. GUTTIERREZ, MPA  
Officer -in-Charge, Director General  
Food and Drug Administration  
DEPARTMENT OF HEALTH  
Name and address (including telephone and fax numbers , email and website 
addresses, if available) of agency or authority designated to handle comments 
regarding the notification shall be indicated if different from above:   
Director IV  
Center for Cosmetics and Household/Urban Hazardous Substances Regulation and 
Research  
Food and Drug Administration  
DEPARTMENT OF HEALTH  
Contact: (02) 8815 -9600 
Email: cchuhsrr -policy@fda.gov.ph  
www.fda.gov.ph   
3. Notified under Article 2.9.2 [X], 2.10.1 [  ], 5.6.2 [  ], 5.7.1 [  ], 3.2 [  ], 7.2 [  ], 
other :  
4. Products covered (HS or CCCN where applicable, otherwise national tariff 
heading. ICS numbers may be provided in addition, where applicable):  Cosmetics. 
Toiletries (ICS code(s): 71.100.70)  
5. Title, number of pages and language(s) of the notified document:  "Updated 
Guidelines on  Product Information File (PIF) for Cosmetic Products Repealing FDA Circular 
No. 2018 -001 "Reiterating the Mandatory Implementation of Article 8 of the ASEAN 
Cosmetic Directive 'Product Information'""; (13 page(s), in English)  
6. Description of content:  This circular shall cover all cosmetic establishments duly 
licensed by the CCHUHSRR who are holders of a valid Certificate of Product Notification 
(CPN).  
7. Objective and rationale, including the nature of urgent problems where 
applicable:  Protection of hu man health or safety  G/TBT/N/PHL/292  
 
- 2 - 
 
  8. Relevant documents:   
• Department of Health (DOH) Administrative Orders (AO) No. 2005 -0015 and 
2005-0025 
• FDA Memorandum Circular (FMC) No. 2015 -011 
• FDA Circular No. 2018 -001 and FDA Advisory No. 2022 -0383 
9. Proposed date of adoption:  Fifteen (15) days after publication in a newspaper of 
general circulation and filing with the University of the Philippines, Office of the National 
Administrative Register  
Proposed date of entry into force:  Fifteen (15) days after publication in a newspaper 
of general circulation and filing with the University of the Philippines, Office of the National 
Administrative Register  
10. Final date for comments:  11 August 2022  
11. Texts available from:  National enquiry point [ ] or address, telephone and fax 
numbers and email and website addresses, if available , of other body:   
Mr. Neil P. Catajay  
Director  
Bureau of Philippine Standards  
Department of Trade and Industry  
3F Trade and Industry Building  
361 Sen. Gil Puyat Avenue  
Makati City  
Philippines  
Tel: (632) 751 4700; (632) 7913128  
Email: bps@dti.gov.ph  
Website: http://www.bps.dti.gov.ph  
https://www.fda.gov.ph/wp -content/uploads/2022/07/Draft -for-Comments -Updated -
Guidelines -on-PIF.pdf  
https://members.wto.org/crnattachments/2022/TBT/PHL/22_5468_00_e.pdf